Study Exploring the Effect of Music on Pain After Ventral Hernia Surgery

July 20, 2023 updated by: Ajita Prabhu, MD, The Cleveland Clinic

The Effect of Music on Pain in Patients Undergoing Ventral Hernia Repair With Mesh: A Double-Blind Randomized Controlled Trial

The purpose of this study is to assess whether listening to music during surgery has an effect on pain or anxiety after surgery.

Study Overview

Detailed Description

After being informed about the study and potential risks and meeting eligibility criteria, all patients giving written informed consent will be scheduled for their hernia repair surgery. On the day of surgery, patients will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to listen to patient-chosen music during their surgery via headphones or just listen to silence via headphones. Pain and anxiety will then be assessed after surgery.

Study Type

Interventional

Enrollment (Actual)

321

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ohio
      • Cleveland, Ohio, United States, 44195
        • Cleveland Clinic Main Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Adults having open retromuscular ventral hernia repair with mesh, with or without myofascial release for a hernia width ≤ 20 cm
  2. Adults having open flank hernia repair that requires a myofascial release with mesh
  3. Adults having parastomal hernia repair with mesh

Exclusion Criteria:

  1. Primary language other than English, or lack of English language fluency
  2. Hearing impairment, with or without use of hearing aids
  3. Neurologic condition that, in the opinion of the investigators, may preclude accurate assessment of postoperative pain and anxiety
  4. Patients who will remain intubated after surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Music Via Headphones
Headphones will be placed with patient-selected music playing for the duration of the surgical procedure.
Music played into headphones.
Placebo Comparator: Silence Via Headphones (Control)
Headphones will be placed with silence for the duration of the surgical procedure.
Silence into headphones.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative Pain
Time Frame: At 24 hours (+- 3 hours) after surgery end time.
Pain scores will be assessed using the Numeric Pain Rating Scale (NRS-11); The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")
At 24 hours (+- 3 hours) after surgery end time.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative Anxiety
Time Frame: At 24 hours (+- 3 hours) after surgery end time.
Anxiety scores will be assessed using State Trait Anxiety Index-6 (STAI-6) Anxiety tool (a 6 question patient-reported anxiety assessment). The higher the total, the greater the anxiety is.
At 24 hours (+- 3 hours) after surgery end time.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative Pain - 3 days
Time Frame: Collected at 3 time points after surgery end time - 24 hours (+- 3 hours), 48 hours (+-3 hours) and 72 hours (+-3 hours)
Pain scores will be assessed using the Numeric Pain Rating Scale (NRS-11); The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")
Collected at 3 time points after surgery end time - 24 hours (+- 3 hours), 48 hours (+-3 hours) and 72 hours (+-3 hours)
Post operative Pain - cumulative
Time Frame: Will be collected repeatedly by nursing staff per nursing protocol for the first 24 hours after surgery end time.
Pain scores will be assessed using the Numeric Pain Rating Scale (NRS-11); The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")
Will be collected repeatedly by nursing staff per nursing protocol for the first 24 hours after surgery end time.
Post operative Anxiety - 3 days
Time Frame: Collected at 3 time points after surgery end time - 24 hours (+- 3 hours), 48 hours (+-3 hours) and 72 hours (+-3 hours)
Anxiety scores will be assessed using State Trait Anxiety Index-6 (STAI-6) Anxiety tool (a 6 question patient-reported anxiety assessment). The higher the total, the greater the anxiety is.
Collected at 3 time points after surgery end time - 24 hours (+- 3 hours), 48 hours (+-3 hours) and 72 hours (+-3 hours)
Post operative opioid consumption
Time Frame: During the first 72 hours after surgery end time.
Cumulative opioid consumption converted into morphine milligram equivalents.
During the first 72 hours after surgery end time.
Intraoperative sedative use
Time Frame: From induction of anesthesia to arrival in the post anesthesia care unit on the day of procedure
Total number of intravenous and inhaled anesthetics, benzodiazepines, and opioid medications.
From induction of anesthesia to arrival in the post anesthesia care unit on the day of procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ajita Prabhu, MD, The Cleveland Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 13, 2022

Primary Completion (Actual)

July 15, 2023

Study Completion (Actual)

July 17, 2023

Study Registration Dates

First Submitted

May 2, 2022

First Submitted That Met QC Criteria

May 11, 2022

First Posted (Actual)

May 16, 2022

Study Record Updates

Last Update Posted (Actual)

July 21, 2023

Last Update Submitted That Met QC Criteria

July 20, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anxiety

Clinical Trials on Patient-Chosen Music

3
Subscribe